Sunway Healthcare Holdings (5555) Fair Value & Analysis
Healthcare · MY · Market cap 22.4B MYR
Fair value as of: Jul 12, 2026
From 16 valuation models · updated 28 days ago
Share price +9.0% over the past month.
A solid business, but screening 81% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (0.4800 MYR). The favourable scenario is already priced in.
- Solid but not exceptional quality (58/100) and above fair value, neither a clear bargain nor a standout compounder.
Price vs Fair Value (5 months)
White line = price, green steps = our fair value per fiscal year. As of Jul 12, 2026.
How to read this chart
5‑month range 1.73 MYR – 2.37 MYR · fair‑value band 0.2900 MYR – 0.4800 MYR · the 2.05 MYR price screens above the 0.3800 MYR fair value. As of Jul 12, 2026.
Analysis
Sunway Healthcare Holdings (5555) currently trades at 2.05 MYR, while our model-based Fair Value estimate is 0.3800 MYR, implying the stock looks roughly 81.5% overvalued today. The Quality Score stands at 58/100 (solid quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).
Over the trailing twelve months, Sunway Healthcare Holdings generated revenue of 2.3B MYR at a net margin of 10.7%. Revenue grew 23.8% year over year. It earns a return on equity of 9.3%. Net debt stands at 1.0B MYR. Fundamentals as of Jul 12, 2026
Our scenario range runs from 0.2900 MYR (bear case) to 0.4800 MYR (bull case); at 2.05 MYR, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 17% below its 52-week high and 21% above its 52-week low, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at 11% fair-value upside, at -81%, 5555 screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 16 models by family
Widest divergence: Growth Earnings (0.8000 MYR) versus Dividend Discount (0.0200 MYR). Highest evidence: Residual Income (76).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 12, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 58 · Market factors (momentum, volatility) 55
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Sunway Healthcare Holdings Berhad, an investment holding company, owns and operates medical centers and facilities in Malaysia.
Full company description
Sunway Healthcare Holdings Berhad, an investment holding company, owns and operates medical centers and facilities in Malaysia. The company provides medical consultation services and facilities, provision of financial services, provision of nursing manpower and nursing care services, operation and provision of traditional and complementary medicine centres, provision of facilities and services for senior living care and assistance, offers ambulatory care services, invests in property, and provision of training services. The company was incorporated in 2021 and is headquartered in Subang Jaya, Malaysia. Sunway Healthcare Holdings Berhad operates as a subsidiary of Sunway City Sdn. Bhd.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2022 – FY2024 · reported fiscal years
Sunway Healthcare Holdings reported revenue of 1.9B MYR in FY2024 versus 1.1B MYR in FY2022, a compound +31.9%/yr. Reported net income was 258M MYR in FY2024, compounding +10.8%/yr from FY2022.
5555 screens 81% overvalued. Compare with HCA Healthcare, Inc →
Peer Group
Medical Care Facilities · 262 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Care Facilities median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 12, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc HCA | $378.85 | $554.93 | +46% |
| Fresenius SE FRE | €41.73 | €32.15 | -23% |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 235.00 SAR | 112.37 SAR | -52% |
| IHH Healthcare Berhad, an investment holding company, Q0F | 2.58 SGD | 1.44 SGD | -44% |
| Tenet Healthcare Corporation THC | $194.91 | $338.05 | +73% |
| Rede D'Or São Luiz S.A RDOR3 | R$36.01 | R$47.31 | +31% |
| DaVita Inc DVA | $231.61 | $255.97 | +11% |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,955 | ₹2,955 | -67% |
| Fresenius Medical Care AG FMS | $24.68 | $45.60 | +85% |
| Aier Eye Hospital Group 300015 | ¥8.68 | ¥7.67 | -12% |
Compare Sunway Healthcare Holdings with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Sunway Healthcare Holdings (5555) overvalued or undervalued?
What is the fair value of 5555?
What is the quality score of 5555?
What is the revenue of Sunway Healthcare Holdings (5555)?
What is the net profit margin of 5555?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Sunway Healthcare Holdings and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.